INS and Insulin resistance: Conversely, PTP-1B−/- mice show enhanced glucose tolerance and increased systemic insulin sensitivity (Elchebly et al., 1999; Behl et al., 2022), indicating that PTP-1B may serve as a potential therapeutic target for improving insulin resistance.